Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis

crackpot submitted, created time 1 year 5 months (www.biomedcentral.com)

"Preventative and therapeutic modulation of macrophage/microglial activity significantly alters the outcome of EAE at symptomatic stages. Specific molecular targets have been identified that represent potential avenues of exploration for the treatment and prevention of MS."

Submit comment | Blog It | Email It | Keywords: macrophageµglial activity disease prevention disease treatment